Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.82 USD | +0.98% | +27.29% | +14.96% |
03/05 | Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio | MT |
02/05 | PHILIPS NV : DZ Bank reiterates its Neutral rating | ZD |
Evolution of the average Target Price on Philips NV
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Philips NV
DZ BANK | Elmar Kraus |
UBS | |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
alphavalue | Anas Patel |
BARCLAYS | Hassan Al-Wakeel |
GOLDMAN SACHS | Richard Felton |
JPMORGAN | David Adlington |
JEFFERIES | Julien Dormois |
HSBC | |
BERNSTEIN RESEARCH | Lisa Bedell Clive |
MORGAN STANLEY | Robert Davies |
Jefferies & Co. | |
Societe Generale | |
JPMorgan Chase | |
Credit Suisse | |
DEUTSCHE BANK | Falko Friedrichs |
KEPLER CHEUVREUX | Oliver Reinberg |
Citigroup | |
BERENBERG | Scott Bardo |
ING Group | |
Deutsche Bank Securities | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- PHIA Stock
- PHG Stock
- Consensus Philips NV